Avant Diagnostics, Inc (AVDX) is a publicly traded company in the Unknown sector. Across all available filings, 21 corporate insiders have executed 547 transactions totaling $115.0M, demonstrating a bearish sentiment with -$113.6M in net insider flow. The most recent transaction on Oct 15, 2025 involved a transaction of 804,014 shares valued at $0.
No significant insider buying has been recorded for AVDX in the recent period.
No significant insider selling has been recorded for AVDX in the recent period.
Based on recent SEC filings, insider sentiment for AVDX is bearish with an Insider Alignment Score of 1/100 and a net flow of -$113.6M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at Avant Diagnostics, Inc (AVDX) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 21 insiders are actively trading AVDX stock, having executed 547 transactions in the past 90 days. The most active insider is Matthew C. Harris (Executive), who has made 7 transactions totaling $95.2M.
Get notified when executives and directors at AVDX file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Oct 15, 2025 | Wilhite Joel | Executive | Disposition | 804,014 | $N/A | $0 | |
| Oct 15, 2025 | Michael Mcguire James | Executive | Disposition | 84,620 | $N/A | $0 | |
| Oct 15, 2025 | Gibson Angelic | Executive | Disposition | 716,036 | $N/A | $0 | |
| Oct 15, 2025 | Stahl Ryan | Executive | Disposition | 550,214 | $N/A | $0 | |
| Oct 15, 2025 | Stahl Ryan | Executive | Other | 134,652 | $N/A | $0 | |
| Oct 15, 2025 | Praeger Michael | Executive | Disposition | 757,327 | $N/A | $0 | |
| Oct 15, 2025 | Praeger Michael | Executive | Other | 9,719,576 | $N/A | $0 | |
| Oct 15, 2025 | Praeger Michael | Executive | Disposition | 1,226,422 | $N/A | $0 | |
| Oct 15, 2025 | Praeger Michael | Executive | Other | 1,888,652 | $N/A | $0 | |
| Oct 15, 2025 | Praeger Michael | Executive | Disposition | 213,468 | $N/A | $0 | |
| Oct 15, 2025 | Praeger Michael | Executive | Other | 1,328,276 | $N/A | $0 | |
| Oct 15, 2025 | Alan Cunningham Todd | Executive | Disposition | 491,075 | $N/A | $0 | |
| Oct 15, 2025 | Chukwu Oni | Executive | Disposition | 40,276 | $N/A | $0 | |
| Oct 15, 2025 | F. Drummond Lance | Executive | Disposition | 82,120 | $N/A | $0 | |
| Oct 15, 2025 | Sambhus Sonali | Executive | Disposition | 61,213 | $N/A | $0 |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Sale(S) | 253 | $114.3M | 93.7% |
Payment(F) | 19 | $2.5M | 2.0% |
Exercise(M) | 194 | $2.4M | 2.0% |
Award(A) | 36 | $2.1M | 1.7% |
Purchase(P) | 3 | $693.6K | 0.6% |
Exercise (Options)(X) | 1 | $35.0K | 0.0% |
Disposition(D) | 17 | $0 | 0.0% |
Other(J) | 7 | $0 | 0.0% |
Gift(G) | 8 | $0 | 0.0% |
Will Acquisition(W) | 1 | $0 | 0.0% |
Conversion(C) | 8 | $0 | 0.0% |
Insider selling pressure at Avant Diagnostics, Inc has increased, with 21 insiders executing 547 transactions across all time. Total sales of $114.3M significantly outpace purchases of $693.6K, resulting in a net outflow of $113.6M. This selling activity appears largely discretionary, which may warrant closer attention from investors.